Completed study

Official Study Title
A double-blind, randomized, placebo-controlled clinical study of the efficacy of INtravenous CLArithromycin as adjunctive treatment in patients with Sepsis and respiratory and multiple organ dysfunction Syndrome

Brief Description
INCLASS is a randomized clinical trial aiming to compare the efficacy of intravenous clarithromycin over placebo in patients with sepsis and respiratory failure.

Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: III
Study sites: 12 (9 sites in Greece, 3 sites in Belgium)
Actual enrolment: 110 participants Identifier: NCT03345992
EudraCT number: 2017-001056-55
National Organization for Medicines Approval: IS 60-17
National Ethics Committee Approval: 64/17

Study Start: December 2017
Study Completion: December 2020

Condition/Disease studied: Sepsis; Pneumonia; Gram-Negative Bacteria Infection; Multiple Organ Failure; Respiratory Distress Syndrome; Mortality; Biomarkers
Keywords: Macrolides

Related publications